News

Lupin introduces generic Glucagon for Injection USP in the US market. Bioequivalent to Eli Lilly's, used for hypoglycemia ...
Truemeds has taken a different route from other Indian online pharmacies — and it has helped the startup double its revenue.
How could Trump's demands that drugmakers lower U.S. prices or face penalties impact pharma and biotech stocks? Seeking Alpha ...
Eli Lilly says it plans to apply for U.S. Food and Drug Administration (FDA) approval by the end of the year to market the ...
How political red tape and a drug company’s thirst for profits limited the reach of a drug that experts believe could have ...
As of fiscal year-end 2025, McKesson held cash and cash equivalents of $5.7 billion with outstanding debt at $4.4 billion. Roughly one third of its debt is due to mature over the next three years, and ...
Cencora is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With over $250 billion in annual US healthcare distribution sales, the company supplies ...
The 340B Drug Pricing Program was created to improve access to care at safety-net hospitals and clinics, but critics argue that the program hasn’t met this goal.
BOSTON, MA / ACCESS Newswire / July 31, 2025 / Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc. (“Radius” or the “Company”), a specialty biopharmaceutical company focused ...
Boryung announced on the 4th that Samsung Bioepis officially launched the bone disease treatment drug "Xbric" in South Korea on the 1st. Xbric is a biosimilar (generic drug for biologics) of the ...